1. Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining
   Xiao-jiao Li et al, 2018, Pathology - Research and Practice CrossRef
2. Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial
   Oliver Dorigo et al, 2023, Clinical Cancer Research CrossRef
3. Survivin is critically involved in VEGFR2 signaling-mediated esophageal cancer cell survival
   Lingxin Meng et al, 2018, Biomedicine & Pharmacotherapy CrossRef
4. Down-regulation of telomerase reverse transcriptase-related anti-apoptotic function in a rat model of acrylamide induced neurobehavioral deficits
   J Wang et al, 2018, Biotechnic & Histochemistry CrossRef